3 terminated, 1 recruiting. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 3, Recruiting 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Metastatic Renal Cancer: new trials by email Literature Review of Metastatic Renal Cancer trials Research Report on Metastatic Renal Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma Sasanlimab, Palbociclib, Axitinib - Metastatic Renal Cell Carcinoma, Metastatic Renal Cancer | Phase 2 | Recruiting | Stephanie Berg | 25 | 2025-11-24 | 2026-08-20 |
| PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI Prednisone + Everolimus - Metastatic Renal Cancer | Phase 2 | Terminated | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 8 | 2015-09-22 | 2018-01-16 |
| MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes PG13-MAGE-A3 TCR9W11 (anti-MAGE-A3/12 TCR) Transduced Autologous Peripheral Blood Lymphocytes, Aldesleukin, Cyclophosphamide - Metastatic Cancer, Metastatic Renal Cancer | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 9 | 2010-12-01 | 2015-10-28 |
| Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer Zanolimumab, Aldesleukin - Metastatic Melanoma, Metastatic Renal Cancer | Phase 2 | Terminated | National Cancer Institute (NCI) | 9 | 2010-06-01 | 2015-10-28 |
Kidney Neoplasms (4) · Carcinoma, Renal Cell (2) · Melanoma (2) · Neoplasm Metastasis (1)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Kidney Diseases (4) · Male Urogenital Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4) · Urologic Diseases (4) · Urologic Neoplasms (4) · Neoplasms by Histologic Type (3) · Adenocarcinoma (2) · Carcinoma (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2)
Interleukin-2 (2) · aldesleukin (2) · Axitinib (1) · Cyclophosphamide (1) · Everolimus (1) · Prednisone (1) · fludarabine (1) · palbociclib (1) · zanolimumab (1)
National Cancer Institute (NCI) (2) · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS (1) · Stephanie Berg (1)
United States (3) · Italy (1)
David S Schrump, M.D. (1) · Stephanie Berg, DO (1) · Steven A Rosenberg, M.D. (1) · Ugo De Giorgi, MD (1)